ABSTRACT
Coronary stenting is the most commonly used method of myocardial revascularization, with approximately 2 million stents implanted in 2004 throughout the world. The development of drug eluting stents has resulted in very low rates of repeat intervention and will further increase the scope for percutaneous coronary intervention.The evidence from larg
TABLE OF CONTENTS
chapter 1|8 pages
Immunoallergic syndromes in interventional cardiology
Chourmouzios A Arampatzis, Giannis Kanonidis, and Patrick W Serruys
chapter 5|16 pages
Dilemmas in non-ST elevation acute coronary syndromes
John A Ambrose, John T Coppola, and Henning Rasmussen
chapter 11|12 pages
Invasive treatment (percutaneous coronary intervention) of patients at high surgical risk
Douglass A Morrison
chapter 14|22 pages
Advanced atherosclerotic diseases in multiple vascular bed sites
Luis A Guzman and Theodore Bass
chapter 15|12 pages
The intermediate coronary lesion Pedro A Lemos, and Patrick W Serruys
Pedro A Lemos and Patrick W Serruys
chapter 17|10 pages
The hypotensive patient after angioplasty: occult life-threatening percutaneous coronary intervention-related complications
Eulógio E Martinez, Marco A Perin, and Luiz J Kajita
chapter 23|22 pages
Large thrombus burden, slow-flow, no-reflow, and distal embolization
Jose A Silva and Christopher J White
chapter 24|10 pages
The role of interventional cardiology in functional coronary stenosis Pedro A Lemos, and Antonio Esteves Filho
Eulógio E Martinez, Nestor F. Mercado, Pedro A Lemos, and Antonio Esteves Filho
chapter 26|16 pages
Coronary interventions in patients with antiplatelet therapy resistance
Dominick J Angiolillo and Marco A Costa
